Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Repromedix was a specialized clinical laboratory and biotechnology company dedicated to the field of reproductive medicine. Based in Woburn, Massachusetts, the company focused on developing and providing high-complexity diagnostic tests for male and female infertility. Their service portfolio included advanced assays such as sperm DNA fragmentation analysis, antisperm antibody detection, and comprehensive panels for recurrent pregnancy loss. Repromedix served fertility clinics and reproductive endocrinologists across the United States, providing critical data to optimize treatment plans for assisted reproduction. In 2006, the company was acquired by InterGenetics to integrate reproductive diagnostics into a broader personalized medicine platform.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Repromedix.